87 related articles for article (PubMed ID: 29097203)
1. Galangin enhances TGF-β1-mediated growth inhibition by suppressing phosphorylation of threonine 179 residue in Smad3 linker region.
Kwak MK; Yang KM; Park J; Lee S; Park Y; Hong E; Sun EJ; An H; Park S; Pang K; Lee J; Kang JM; Kim P; Ooshima A; Kim SJ
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):706-713. PubMed ID: 29097203
[TBL] [Abstract][Full Text] [Related]
2. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
[TBL] [Abstract][Full Text] [Related]
3. Heme oxygenase-1/carbon monoxide axis suppresses transforming growth factor-β1-induced growth inhibition by increasing ERK1/2-mediated phosphorylation of Smad3 at Thr-179 in human hepatocellular carcinoma cell lines.
Park SJ; Lee SK; Lim CR; Park HW; Liu F; Kim SJ; Kim BC
Biochem Biophys Res Commun; 2018 Apr; 498(3):609-615. PubMed ID: 29524413
[TBL] [Abstract][Full Text] [Related]
4. The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region.
Jeon WK; Choi J; Park SJ; Jo EJ; Lee YK; Lim S; Kim JH; Letterio JJ; Liu F; Kim SJ; Kim BC
Oncotarget; 2015 Dec; 6(39):41650-66. PubMed ID: 26497676
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation status at Smad3 linker region modulates transforming growth factor-β-induced epithelial-mesenchymal transition and cancer progression.
Ooshima A; Park J; Kim SJ
Cancer Sci; 2019 Feb; 110(2):481-488. PubMed ID: 30589983
[TBL] [Abstract][Full Text] [Related]
6. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen peroxide inhibits transforming growth factor-β1-induced cell cycle arrest by promoting Smad3 linker phosphorylation through activation of Akt-ERK1/2-linked signaling pathway.
Choi J; Park SJ; Jo EJ; Lee HY; Hong S; Kim SJ; Kim BC
Biochem Biophys Res Commun; 2013 Jun; 435(4):634-9. PubMed ID: 23685151
[TBL] [Abstract][Full Text] [Related]
8. Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition in renal epithelial cells.
Bae E; Kim SJ; Hong S; Liu F; Ooshima A
Biochem Biophys Res Commun; 2012 Oct; 427(3):593-9. PubMed ID: 23022526
[TBL] [Abstract][Full Text] [Related]
9. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
10. Galangin attenuates airway remodelling by inhibiting TGF-β1-mediated ROS generation and MAPK/Akt phosphorylation in asthma.
Liu YN; Zha WJ; Ma Y; Chen FF; Zhu W; Ge A; Zeng XN; Huang M
Sci Rep; 2015 Jul; 5():11758. PubMed ID: 26156213
[TBL] [Abstract][Full Text] [Related]
11. Impaired mammary tumor formation and metastasis by the point mutation of a Smad3 linker phosphorylation site.
Huang CC; Huang MS; Chung HJ; Chiu SY; Yadav P; Lin Y; Liu F; Matsuura I
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3664-3671. PubMed ID: 30251686
[TBL] [Abstract][Full Text] [Related]
12. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H
Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046
[TBL] [Abstract][Full Text] [Related]
13. Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.
Miles FL; Tung NS; Aguiar AA; Kurtoglu S; Sikes RA
Prostate; 2012 Sep; 72(12):1339-50. PubMed ID: 22228025
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-β1 tumor suppressor activity by binding to Smad3 to interrupt its complex formation with Smad4.
Park Y; Kim W; Lee JM; Park J; Cho JK; Pang K; Lee J; Kim D; Park SW; Yang KM; Kim SJ
Oncogene; 2015 Sep; 34(39):5037-45. PubMed ID: 25531329
[TBL] [Abstract][Full Text] [Related]
15. Indoxyl sulfate enhances p53-TGF-β1-Smad3 pathway in proximal tubular cells.
Shimizu H; Yisireyili M; Nishijima F; Niwa T
Am J Nephrol; 2013; 37(2):97-103. PubMed ID: 23363842
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide inhibits transforming growth factor-beta1-stimulated Smad6 expression by inducing phosphorylation of the linker region of Smad3 through a TLR4-IRAK1-ERK1/2 pathway.
Kim EY; Kim BC
FEBS Lett; 2011 Mar; 585(5):779-85. PubMed ID: 21295571
[TBL] [Abstract][Full Text] [Related]
17. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Da C; Liu Y; Zhan Y; Liu K; Wang R
Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
[TBL] [Abstract][Full Text] [Related]
18. Galangin inhibits human osteosarcoma cells growth by inducing transforming growth factor-β1-dependent osteogenic differentiation.
Liu C; Ma M; Zhang J; Gui S; Zhang X; Xue S
Biomed Pharmacother; 2017 May; 89():1415-1421. PubMed ID: 28340520
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3beta negatively regulates TGF-beta1 and Angiotensin II-mediated cellular activity through interaction with Smad3.
Hua F; Zhou J; Liu J; Zhu C; Cui B; Lin H; Liu Y; Jin W; Yang H; Hu Z
Eur J Pharmacol; 2010 Oct; 644(1-3):17-23. PubMed ID: 20599907
[TBL] [Abstract][Full Text] [Related]
20. The essential role for c-Ski in mediating TGF-beta1-induced bi-directional effects on skin fibroblast proliferation through a feedback loop.
Liu X; Li P; Liu P; Xiong R; Zhang E; Chen X; Gu D; Zhao Y; Wang Z; Zhou Y
Biochem J; 2008 Jan; 409(1):289-97. PubMed ID: 17725545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
